-
Study aim
-
Evaluation of changes in the levels of adipokines (adiponectin, resistin, ghrelin, leptin) and cytokines (tumor necrosis factor-alpha and C-reactive protein) and signs of puberty (bone age, ovarian and uterine size, levels of luteinizing hormone and follicle-stimulating hormone) and mental health after 12 weeks of combined exercise and 4 weeks of detraining
-
Design
-
Clinical trial with control group, parallel, non-blind, randomised, phase 1 groups on 30 patients
-
Settings and conduct
-
The 12-weeks intervention in exercise group involved a physical activity program with 3 60-min sessions/week consisted of 30 min of aerobic exercise with an intensity of 55% to 65% of individual maximal cardio-respiratory fitness followed by 20 min of strengthening exercises and 10 min of stretching and cool-down Which is done by two experienced coaches in the sports hall of the civil town of Hamedan. Sampling is done before the start of the exercise protocol, after 12 weeks of exercise and after 4 weeks of detraining.
-
Participants/Inclusion and exclusion criteria
-
The inclusion criteria: 1. Girls with central precocious puberty; 2. Having a BMI higher than 19; 3.The age range of 7 to 9 years; 4. taking about one year before a diagnosis had been made; 5. Being on medication for one year; 6. Being treated with Differlin drug ; 7. Taking medication 1 ml every 28 days.
The exclusion criteria: 1. having another illness; 2. taking another medicine; 3. having a special diet; 4. being active in another sport; 5. being connected to drugs.
-
Intervention groups
-
intervention and control group
-
Main outcome variables
-
adiponectin, resistin, ghrelin, leptin, tumor necrosis factor-alpha, C-reactive protein, bone age, ovarian and uterine size, luteinizing hormone and follicle-stimulating hormone, mental health